pISSN 2636-0004
eISSN 2636-0012

Table. 2.

Clinical Outcomes of G-POEM

Study No. of patients Technical success (%) Clinical success (%) Parameters to assess clinical success Functional outcomes (%) Adverse events Follow-up (mo)*
Shlomovitz et al (2015)17 7 100 86 (6/7) GCSI 80 (4/5) 1 Bleeding (clips) 6.5 ± 2.1
Khashab et al (2017)18 30 100 87 (26/30) GCSI, GES 47 (14/30) 1 Capnoperitoneum, 1 ulcer 5.5
Gonzalez et al (2017)19 12 100 83 (10/12) GCSI, GES 75 (9/12) 2 Capnoperitoneum 5
Mekaroonkamol et al (2016)20 3 100 100 (3/3) GCSI, GES 100 (3/3) Nil 3
Gonzalez et al (2017)21 29 100 3 mo: 79 GCSI, GES 55 (16/29) 1 Bleeding (clips), 1 abscess (conservative) 10 ± 6.4
6 mo: 69
Dacha et al (2017)22 16 100 81 (13/16) GCSI, GES 75 (12/16) Nil 6
Rodriguez et al (2017)23 47 100 66 (31/47) GCSI, GES 34 (16/47) 1 Death (cardiac disease, unrelated to procedure) 3
Kahaleh et al (2018)24 33 100 85 (28/33) GCSI, GES 100 1 Bleeding (clips), 1 ulcer 11.5
Xu et al (2018)25 16 100 81 (13/16) GCSI, GES 100 NR 14.5
Malik et al (2018)26 13 100 73 (8/11) GES, PAGI-SYM PAGI-SYM: 72.7 Nil 3
GES: 66.6
Mekaroonkamol et al (2019)27 30 100 76.7 GCSI, GES GES: 78.3 NR 18
GCSI
1 mo: 80
6 mo: 71
12 mo: 57
18 mo: 67
Vosoughi et al (2020)28 37 100 70 EndoFLIP EndoFLIP prediction: NR 3
specificity 91;
sensitivity 71

G-POEM, gastric per-oral endoscopic pyloromyotomy; GCSI, gastric cardinal symptom index; GES, gastric emptying scintigraphy; PAGI-SYM, patient assessment of gastrointestinal symptoms; EndoFLIP, endoluminal functional luminal imaging probe; NR, not reported.

*Values are presented as mean ± standard deviation or median.

Int J Gastrointest Interv 2020;9:72~77 https://doi.org/10.18528/ijgii200014
© Int J Gastrointest Interv